Quest Diagnostics (DGX) debt: $5.7B
Quest Diagnostics had $5.7B of long-term debt on Dec 31, 2025, including the part due within a year, down 8.8% from $6.2B a year earlier.
From Quest Diagnostics's filings with the SEC · Read the filing · DGX stock page
Quest Diagnostics debt by year
#289 of 2,129 US companies by debt · See the full ranking
| Year ended | Debt | Change |
|---|---|---|
| Dec 31, 2025 | $5.7B | -9% |
| Dec 31, 2024 | $6.2B | +32% |
| Dec 31, 2023 | $4.7B | +18% |
| Dec 31, 2022 | $4B | -1% |
| Dec 31, 2021 | $4B | – |
Debt of similar companies
Companies in the same industry as Quest Diagnostics, by SEC industry code, with the closest debt. Each name opens the same page for that company.
| Company | Debt, latest year | Year ended |
|---|---|---|
| Quest Diagnostics | $5.7B | Dec 31, 2025 |
| Labcorp | $5.6B | Dec 31, 2025 |
| Guardant Health | $1.5B | Dec 31, 2025 |
| RadNet | $1.1B | Dec 31, 2025 |
| Fortrea | $1.1B | Dec 31, 2025 |
| Caris Life Sciences | $378M | Dec 31, 2025 |
| Celcuity | $138M | Dec 31, 2025 |
Questions and answers
What is Quest Diagnostics's debt?
Quest Diagnostics had $5.7B of long-term debt on Dec 31, 2025, including the part due within a year, down 8.8% from $6.2B a year earlier.
Numbers as reported in Quest Diagnostics's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology